Navigator Medicines

Navigator Medicines is a biotech company focused on developing biologics for targeted immune regulation and restoration. They are committed to creating new therapies for patients with complex autoimmune diseases, with a current focus on NAV-240, a bispecific antibody therapeutic. Their pipeline includes both mono- and bispecific antibodies targeting OX40L.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $100M

Date: 27-Aug-2024

Investors: RA Capital Management, Forbion

Markets: Biotechnology, Pharmaceuticals, Immunotherapy, Life Science

HQ: Scotch Plains, New Jersey, United States

Founded: 2024

Website: https://www.navigatormedicines.com/

LinkedIn: https://www.linkedin.com/company/navigator-medicines-inc/

Twitter:

Instagram: